Skip to main content
TipRanks
Go Ultimate75% OFF

Redcare Pharmacy (SAE) Stock Price & Analysis

2 Followers

SAE Stock Chart & Stats

CHF 65.25CHF 0.00(0.00%)
At close: 5:30 PM GMT+1
CHF55CHF60CHF65Sep 23Sep 28Sep 29Oct 30Nov 9
Day’s Range
CHF 61.55 - CHF 65.25
52-Week Range
CHF 27.80 - CHF 75.25
Previous Close
CHF 65.25
Volume
N/A
Average Volume (3M)
10
Market Cap
CHF 1.29B
Enterprise Value
CHF 1.72B
Total Cash (Recent Filing)
CHF 132.40M
Total Debt (Recent Filing)
CHF 354.50M
Price to Earnings (P/E)
―
Beta
-0.14
Next Earnings
Mar 03, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Sustained revenue expansion shows that Redcare is increasing its commercial scale across online pharmacy and health products. A larger sales base can improve purchasing leverage, spread fixed logistics costs, and support continued investment in customer acquisition and fulfillment capacity.

Improving Losses And Operating Cash Flow

Positive operating cash flow and narrower losses indicate that the business is moving toward better operating economics, even though it is not yet profitable. Continued improvement could reduce reliance on external funding and provide more flexibility to support growth initiatives.

Stable Capital Base

A substantial and broadly stable equity base provides Redcare with financial capacity relative to its asset scale. Historically manageable leverage can support ongoing investment in its platform and distribution operations, although the reported debt figures remain a factor to monitor.

Bears Say

Persistent Net Losses

Redcare remains loss-making despite its large revenue base, while operating profit is modest relative to sales. Persistent negative earnings constrain internally funded growth, weaken returns on shareholder capital, and leave the company more exposed if progress toward profitability stalls.

Gross Margin Compression

The sustained decline in gross margin reduces the amount of revenue available to cover fulfillment, marketing, technology, and corporate costs. Unless the business improves product mix or operating efficiency, margin compression will limit earnings leverage even as sales continue to grow.

Negative Free Cash Flow

Negative free cash flow means operating cash generation is not currently sufficient after reinvestment and working-capital demands. If this pattern persists, Redcare may need additional financing to sustain expansion, reducing financial flexibility and increasing dependence on capital markets.

Redcare Pharmacy News

SAE FAQ

What was Redcare Pharmacy’s price range in the past 12 months?
Redcare Pharmacy lowest stock price was CHF27.80 and its highest was CHF75.25 in the past 12 months.
What is Redcare Pharmacy’s market cap?
Redcare Pharmacy’s market cap is CHF1.29B.
When is Redcare Pharmacy’s upcoming earnings report date?
Redcare Pharmacy’s next earnings report is estimated for Mar 03, 2027 (not yet confirmed), which is in 105 days.
How were Redcare Pharmacy’s earnings last quarter?
Redcare Pharmacy released its earnings results on Oct 29, 2026. The company reported -CHF0.009 earnings per share for the quarter, missing the consensus estimate of CHF0.06 by -CHF0.07.
Is Redcare Pharmacy overvalued?
According to Wall Street analysts Redcare Pharmacy’s price is currently Undervalued.
Does Redcare Pharmacy pay dividends?
Redcare Pharmacy does not currently pay dividends.
What is Redcare Pharmacy’s EPS estimate?
Redcare Pharmacy’s EPS estimate is -0.24.
How many shares outstanding does Redcare Pharmacy have?
Redcare Pharmacy has 20,578,390 shares outstanding.
What happened to Redcare Pharmacy’s price movement after its last earnings report?
Redcare Pharmacy reported an EPS of -CHF0.009 in its last earnings report, missing expectations of CHF0.06. Following the earnings report the stock price went down -0.977%.
Which hedge fund is a major shareholder of Redcare Pharmacy?
Currently, no hedge funds are holding shares in CH:SAE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology